Download PDF

Other users also viewed these articles

Is the use of secukinumab after anti-TNF therapy greater than expected for the risk of developing inflammatory bowel disease? Fatih Albayrak; Mustafa Gür; Ahmet Karata¿; Süleyman Serdar Koca; Bünyamin K¿sac¿k;
Reumatol Clin. 2024;20:123-7
Patients with spondyloarthritis including psoriatic arthritis: Current needs, impact, and perspective Estíbaliz Loza; Pedro Plazuelo; Ceade;
Reumatol Clin. 2023;19:273-8
Biological treatment patterns in patients with inflammatory joint diseases. Retrospective study with 4 years follow-up Juan D. Cañete; Antonio Naranjo; Javier Calvo; Carmen Ordás; Belén Aragón; Gonzalo Nocea; Montse Roset; Antonio Fernández-Nebro;
Reumatol Clin. 2020;16:447-54